LONDON (Reuters) - A legal case over access to details of clinical trials held by Europe's drugs regulator - sparked by two U.S. firms wanting to keep their data secret - has been hit by delay after the EU's top court sent it back to be re-examined by a lower body.

via Reuters: Health News Read More Here..
No comments:
Post a Comment